Market cap
₹9 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
12.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -65.52 | -16.28 | -10.66 |
| EBIT | 3.42 | -11,400.00 | -290.24 | -42.91 | 12.26 |
| Net Profit | 3.42 | -969.23 | -229.19 | -22.22 | 12.54 |
| EPS | 3.42 | -967.72 | -229.15 | -22.20 | 12.54 |
| Book Value | -- | -- | 12.52 | 4.76 | -16.61 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| 4.67 | -39.25 | -61.26 | 12.25 | 5.42 |
| Net Margin
| -- | -- | -50.86 | -- | -- |
| Return on equity
| 4.65 | -17.70 | -24.67 | 11.78 | 7.43 |
| Return on Capital
| 1.19 | -7.35 | -- | 2.94 | 1.74 |
| Return on Assets
| 1.14 | -6.69 | -6.28 | 2.97 | 1.73 |
| Debt to Equity (x)
| -- | -- | 2.85 | 2.77 | 3.18 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
2.94
|
1.74
|
-1.10
|
-16.66
|
|
Peer Median
|
--
|
14.72
|
18.85
|
11.60
|
--
|
ROE
-24.67
Lower than Peers by 35.53
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-24.67
|
11.78
|
7.43
|
-5.28
|
-49.49
|
|
Peer Median
|
10.86
|
11.67
|
14.92
|
11.46
|
--
|
ROA
-6.28
Lower than Peers by 13.02
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-6.28
|
2.97
|
1.73
|
-1.29
|
-16.05
|
|
Peer Median
|
6.74
|
7.86
|
9.06
|
6.44
|
--
|
EBIT Margin
-61.26
Lower than Peers by 73.95
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-61.26
|
12.25
|
5.42
|
-3.67
|
-118.32
|
|
Peer Median
|
12.69
|
15.03
|
14.71
|
12.37
|
--
|
Net Margin
-50.86
Lower than Peers by 59.72
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-50.86
|
12.38
|
5.47
|
-4.39
|
-120.19
|
|
Peer Median
|
8.86
|
9.33
|
8.49
|
10.02
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
0.00
|
12.41
|
6.12
|
-3.77
|
-119.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-65.52
Lower than Peers by 73.66
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-65.52
|
-22.75
|
14.15
|
114.19
|
-58.27
|
|
Peer Median
|
8.14
|
10.27
|
11.85
|
9.08
|
--
|
EBIT Growth
-290.24
Lower than Peers by 307.49
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-290.24
|
74.43
|
268.68
|
93.36
|
46.28
|
|
Peer Median
|
17.24
|
24.15
|
28.00
|
-3.12
|
--
|
Net Profit Growth
-229.19
Lower than Peers by 246.05
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-229.19
|
74.83
|
242.39
|
92.18
|
44.93
|
|
Peer Median
|
16.85
|
30.29
|
36.51
|
-0.85
|
--
|
EPS Growth
-229.15
Lower than Peers by 239.75
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-229.15
|
74.73
|
242.28
|
92.18
|
44.93
|
|
Peer Median
|
10.60
|
24.50
|
--
|
-6.82
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
12.52
|
7.72
|
-5.14
|
-39.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
2.85
Higher than Peers by 2.80
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
2.85
|
2.77
|
3.18
|
3.29
|
2.75
|
|
Peer Median
|
0.04
|
0.23
|
0.20
|
0.15
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
--
|
--
|
1.79
|
1.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
38.60
Higher than Peers by 36.88
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
38.60
|
73.30
|
68.84
|
0.61
|
0.48
|
|
Peer Median
|
1.72
|
1.79
|
1.96
|
2.08
|
--
|
Quick Ratio
38.60
Higher than Peers by 37.43
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
38.60
|
73.30
|
68.84
|
0.61
|
0.48
|
|
Peer Median
|
1.17
|
1.47
|
1.44
|
1.58
|
--
|
Interest Coverage
-207.00
Lower than Peers by 214.86
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-207.00
|
71.14
|
15.03
|
-8.26
|
-102.33
|
|
Peer Median
|
7.86
|
9.42
|
8.58
|
15.41
|
--
|
Operating Efficiency
Debtors to sales
13.87
Lower than Peers by 11.91
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
13.87
|
54.35
|
41.99
|
49.18
|
31.35
|
|
Peer Median
|
25.79
|
25.82
|
26.12
|
22.96
|
--
|
Asset Turnover
0.12
Lower than Peers by 0.55
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
0.12
|
0.24
|
0.32
|
0.30
|
0.13
|
|
Peer Median
|
0.67
|
0.75
|
0.77
|
0.65
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
198.39
|
155.26
|
116.47
|
318.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
0.81
|
18.90
|
21.18
|
225.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
197.57
|
136.37
|
95.28
|
93.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-42.93
Lower than Peers by 82.83
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-42.93
|
71.05
|
129.03
|
--
|
--
|
|
Peer Median
|
39.90
|
39.70
|
33.48
|
37.74
|
--
|
Price / Book Value
12.58
Higher than Peers by 8.34
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
12.58
|
7.91
|
9.24
|
7.30
|
5.50
|
|
Peer Median
|
4.23
|
3.72
|
4.21
|
3.22
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
0.16
|
0.21
|
0.57
|
--
|
EV/EBITDA
-59.62
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
-59.62
|
96.69
|
155.76
|
-280.16
|
-12.81
|
|
Peer Median
|
--
|
30.23
|
29.90
|
28.81
|
--
|
Market Cap
9
Lower than Peers by 7,604
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
9
|
7
|
7
|
5
|
4
|
|
Peer Median
|
7,613
|
4,851
|
2,099
|
15,272
|
--
|